文献速递多重用药衰弱、肌少症与跌倒

养老院老年居民处方精简干预的健康结局:系统综述与荟萃分析

Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis.
PubMed 文献 · J Am Med Dir Assoc · 2018-12-21

该系统综述与荟萃分析纳入41项随机对照试验共18408名养老院老年居民,评估处方精简干预对跌倒、全因死亡、住院和潜在不适当用药的影响。处方精简干预显著减少潜在不适当用药居民数量达59%,药物审查导向的处方精简干预还降低全因死亡26%和跌倒者数量24%。

要点

  • 处方精简干预显著减少养老院老年居民潜在不适当用药达59%。
  • 药物审查导向的处方精简降低全因死亡26%和跌倒者24%。
  • 药物审查导向的处方精简相比其他干预对养老院老年居民有显著获益。

核心结论

  • 处方精简干预显著减少养老院老年居民潜在不适当用药居民数量达59%(OR 0.41, 95%CI 0.19-0.89)。
  • 药物审查导向的处方精简干预降低全因死亡26%(OR 0.74, 95%CI 0.65-0.84)和跌倒者数量24%(OR 0.76, 95%CI 0.62-0.93)。
  • 与其他处方精简干预相比,药物审查导向的处方精简对养老院老年居民有显著获益。

研究设计与样本

  • 系统综述与荟萃分析,检索CINAHL、International Pharmaceutical Abstracts、MEDLINE、EMBASE和Cochrane Library自建库至2017年9月,并手工检索系统综述参考文献列表和在线试验注册库。
  • 纳入养老院环境中年龄至少60岁参与者的随机对照试验,共41项随机临床研究(18408名居民)。
  • 处方精简定义为停药、换药或减量;荟萃分析评估跌倒、全因死亡、住院和潜在不适当用药。

主要发现

  • 处方精简干预显著减少潜在不适当用药居民数量达59%(OR 0.41, 95%CI 0.19-0.89)。
  • 亚组分析中,药物审查导向的处方精简干预降低全因死亡26%(OR 0.74, 95%CI 0.65-0.84)。
  • 亚组分析中,药物审查导向的处方精简干预减少跌倒者数量24%(OR 0.76, 95%CI 0.62-0.93)。

临床怎么用

  • 在养老院老年居民中实施处方精简干预,尤其是药物审查导向的处方精简,可减少潜在不适当用药并可能降低死亡和跌倒风险。

局限性

  • 需要进一步研究以揭示药物审查导向处方精简实践的其他临床获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Deprescribing is effective in addressing concerns relating to polypharmacy in residents of nursing homes. However, the clinical outcomes of deprescribing interventions among residents in nursing homes are not well understood. We evaluated the impact of deprescribing interventions by health care professionals on clinical outcomes among the older residents in nursing homes. DESIGN: Systematic review and meta-analysis of randomized controlled trials. CINAHL, International Pharmaceutical Abstracts, MEDLINE, EMBASE, and Cochrane Library were searched from inception until September 2017; manual searches of reference lists of systematic reviews identified in the electronic search; and online trial registries for unpublished, ongoing, or planned trials. (PROSPERO CRD42016050028). SETTING AND PARTICIPANTS: Randomized controlled trials in a nursing home setting that included participants of at least 60 years of age. MEASURES: Falls, all-cause mortality, hospitalization, and potentially inappropriate medication were assessed in the meta-analysis. RESULTS: A total of 41 randomized clinical studies (18,408 residents) that examined deprescribing (defined as either medication discontinuation, substitution, or reduction) in nursing were identified. Deprescribing interventions significantly reduced the number of residents with potentially inappropriate medications by 59% (odds ratio [OR] 0.41, 95% confidence interval [CI] 0.19-0.89). In subgroup analysis, medication review-directed deprescribing interventions reduced all-cause mortality by 26% (OR 0.74, 95% CI 0.65-0.84), as well as the number of fallers by 24% (OR 0.76, 95% CI 0.62-0.93). CONCLUSIONS: Compared to other deprescribing interventions, medication review-directed deprescribing had significant benefits on older residents in nursing homes. Further research is required to elicit other clinical benefits of medication review-directed deprescribing practice.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Kua CH, Mak VSL, Huey Lee SW, et al. Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis. J Am Med Dir Assoc. 2018. PMID: 30581126. doi:10.1016/j.jamda.2018.10.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。